Journal article

Re: Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Philippou, Y., Protheroe, A. S., & Bryant, R. J. (2020). Re: Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study. European Urology, 77(6), 759–760.

MLA Style

Philippou, Y., et al. “Re: Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.” European Urology, vol. 77, no. 6, Elsevier, 2020, pp. 759–60.

Chicago Style

Philippou, Y, AS Protheroe, and RJ Bryant. 2020. “Re: Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.” European Urology 77 (6): 759–60.
Share
Print

Access Document

Files:: Submitted_Words_of_wisdom_180120.pdf

(Preview, Accepted manuscript, 107.5KB, Terms of use)

Publisher copy:: 10.1016/j.eururo.2020.02.026

Authors

+ Philippou, Y More by this author

Role:: Author

+ Protheroe, AS More by this author

Role:: Author

+ Bryant, RJ More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Surgical Sciences
Oxford college:: St Anne's College
Role:: Author
ORCID:: 0000-0002-8330-9251

Publisher:: Elsevier
Journal:: European Urology More from this journal
Volume:: 77
Issue:: 6
Pages:: 759-760
Publication date:: 2020-02-27
Acceptance date:: 2020-02-19
DOI:: 10.1016/j.eururo.2020.02.026
EISSN:: 1873-7560
ISSN:: 0302-2838
Pmid:: 32115263

Language:: English
Keywords:: FFR
Pubs id:: 1090175
Local pid:: pubs:1090175
Deposit date:: 2020-03-29

Terms of use

Copyright holder:: Elsevier B.V.
Copyright date:: 2020
Rights statement:: © 2020 Published by Elsevier B.V. on behalf of European Association of Urology.
Notes:: This is the accepted manuscript version of the article. The final version is available from Elsevier at https://doi.org/10.1016/j.eururo.2020.02.026

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP